Log in

LON:GLBGlanbia Share Price, Forecast & News

GBX 9.65
+0.36 (+3.88 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: GBX 9.65
50-Day Range
MA: GBX 10.20
52-Week Range
Now: GBX 9.65
Volume20,368 shs
Average Volume224,675 shs
Market Capitalization£28.57 million
P/E Ratio15.85
Dividend Yield2.52%
Glanbia plc operates as a nutrition company. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, e-Commerce, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment engages in the manufacture and sale of cheese, dairy and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment produces and sells a range of value added dairy ingredients and consumer products. This segment also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, SlimFast, BSN, Isopure, Nutramino, ABB, think!, Amazing Grass, and Body & Fit brands. The company has operations in North America, Europe, and internationally. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.02 out of 5 stars

Industry, Sector and Symbol

Industry Food - Major Diversified



Sales & Book Value

Annual Sales£3.88 billion
Cash FlowGBX 87.49 per share
Book ValueGBX 576.50 per share



Market Cap£28.57 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 9.65
+0.36 (+3.88 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GLB News and Ratings via Email

Sign-up to receive the latest news and ratings for GLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Glanbia (LON:GLB) Frequently Asked Questions

How has Glanbia's stock been impacted by COVID-19?

Glanbia's stock was trading at GBX 10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GLB stock has decreased by 3.5% and is now trading at GBX 9.65.
View which stocks have been most impacted by COVID-19

How often does Glanbia pay dividends? What is the dividend yield for Glanbia?

Glanbia declared a dividend on Wednesday, August 12th. Stockholders of record on Thursday, August 20th will be paid a dividend of GBX 0.11 per share on Friday, October 2nd. This represents a yield of 1.2%. The ex-dividend date is Thursday, August 20th. The official announcement can be accessed at this link.
View Glanbia's dividend history

Has Glanbia been receiving favorable news coverage?

News headlines about GLB stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Glanbia earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.
View the latest news about Glanbia

Who are some of Glanbia's key competitors?

What other stocks do shareholders of Glanbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Glanbia investors own include Reckitt Benckiser Group (RB), KERRY GRP PLC/S (KRYAY), Kimberly Clark (KMB), Glanbia (GLAPY), Glanbia (GLAPF), Diageo (DEO), Dalata Hotel Group (DAL), Bank of Ireland Group (BIRG), Atalaya Mining (ATYM) and Amryt Pharma (AMYT).

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 56, Pay $1.39M)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 56, Pay $1.02M)
  • Mr. Brian Phelan, Chief Exec. Officer of Glanbia Nutritionals (Age 53, Pay $289k)
  • Mr. Hugh McGuire, Chief Exec. Officer of Glanbia Performance Nutrition (Age 49, Pay $222k)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations

What is Glanbia's stock symbol?

Glanbia trades on the London Stock Exchange (LON) under the ticker symbol "GLB."

How do I buy shares of Glanbia?

Shares of GLB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Glanbia's stock price today?

One share of GLB stock can currently be purchased for approximately GBX 9.65.

How big of a company is Glanbia?

Glanbia has a market capitalization of £28.57 million and generates £3.88 billion in revenue each year. Glanbia employs 7,385 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House, KILKENNY,, Ireland. The company can be reached via phone at +353-56-7772200.

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.